NCT07533344 2026-04-16
PSMA-MRI BX
Fatih Sultan Mehmet Training and Research Hospital
Completed
Clinical Trials
532 trialsNCT07491406 2026-03-24
PRS-AS
IRCCS San Raffaele
Completed
NCT07485257 2026-03-20
MP-PET-MRI
IRCCS San Raffaele
Completed
NCT07477756 2026-03-19
A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients
Novartis
Completed
NCT07428642 2026-03-18
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
First Affiliated Hospital of Wenzhou Medical University
Completed
NCT07448545 2026-03-05
Turkish Version of the UCLA Prostate Cancer Index
Lokman Hekim University
Completed
NCT07450157 2026-03-04
A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617
Novartis
Completed
NCT03159676 2026-02-25
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer
Mayo Clinic
Completed
NCT04048252 2026-02-18
PROSTED
Centre Hospitalier Universitaire de NÄ«mes
Completed
NCT02313623 2026-02-12
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
Yale University
Completed
NCT06253065 2026-02-11
Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Completed
NCT00893035 2026-02-05
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
Institut du Cancer de Montpellier - Val d'Aurelle
Completed
NCT03707574 2026-02-04
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
National Cancer Institute (NCI)
Completed
NCT04484246 2026-02-04
HoSAGE
Assistance Publique Hopitaux De Marseille
Completed
NCT06764992 2026-02-04
Exploring Men s Prostate Cancer Genetic Risk Perceptions
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT06273735 2026-02-03
Prospective Trial: Acute Myocardial Injury After Radical Prostatectomy
Martini-Klinik am UKE GmbH
Completed
NCT05701007 2026-01-29
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
Completed
NCT03516110 2026-01-23
PRISME
Ipsen
Completed
NCT00186368 2026-01-12
Microarray Analysis of Gene Expression in Prostate Tissues
Stanford University
Completed
NCT02189486 2026-01-07
Prostate Cancer Upgrading Reference Set
The University of Texas Health Science Center at San Antonio
Completed
NCT06072196 2025-12-31
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Pfizer
Completed
NCT01823549 2025-12-29
Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients
Ohio State University Comprehensive Cancer Center
Completed
NCT02657863 2025-12-23
Cancer DNA Detection in Blood and Urine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT06783088 2025-12-23
QUADO
Central Hospital, Nancy, France
Completed
NCT06055946 2025-12-22
BARVANA LONG
Aesculap AG
Completed
NCT04034095 2025-12-15
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
Janssen Pharmaceutical K.K.
Completed
NCT04465214 2025-12-15
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
National Institutes of Health Clinical Center (CC)
Completed
NCT05970471 2025-12-12
IMPLICATION
Centre Hospitalier Universitaire de Besancon
Completed
NCT06462014 2025-12-11
Description of Relugolix Use in Patients With Prostate Cancer Within the VHA
Pfizer
Completed
NCT07086651 2025-12-08
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)
Pfizer
Completed
NCT04501913 2025-12-05
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
City of Hope Medical Center
Completed
NCT03232411 2025-12-04
Biobank for African American Prostate Cancer Research in Florida
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT03284684 2025-12-01
Periop ctDNA
Centre Hospitalier Universitaire de NÄ«mes
Completed
NCT07242144 2025-11-28
Effect of Changes in Endotracheal Tube Cuff Pressure on Postoperative Pharyngolaryngeal Complications in Robotic Surgery
Ege University
Completed
NCT02854982 2025-11-21
EPICAP-QALY
Centre Hospitalier Universitaire de NÄ«mes
Completed
NCT04702633 2025-11-20
PROSTA-PAP
Assistance Publique - Hôpitaux de Paris
Completed
NCT04560452 2025-10-08
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
AstraZeneca
Completed
NCT07206693 2025-10-03
Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial Emulation
Karolinska Institutet
Completed
NCT05819606 2025-09-22
PER2PSMA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Completed
NCT02170181 2025-09-17
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
University of Texas Southwestern Medical Center
Completed
NCT05323747 2025-09-16
BP-008
BioProtect
Completed
NCT05354427 2025-09-16
CLP-10095
BioProtect
Completed
NCT03967080 2025-09-03
ARPC-MRI
East and North Hertfordshire NHS Trust
Completed
NCT03275181 2025-09-02
Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer
Kansas State University
Completed
NCT06589154 2025-09-02
The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis
Shanghai Changzheng Hospital
Completed
NCT01777802 2025-08-27
SBRT
Mayo Clinic
Completed
NCT07134504 2025-08-21
Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.
Instituto Mexicano del Seguro Social
Completed
NCT05533515 2025-08-19
C-ProMeta-1
Queen Mary University of London
Completed
NCT04553926 2025-08-14
OLAP
AstraZeneca
Completed
NCT05202301 2025-08-11
A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely
Bayer
Completed